This research study is looking to see how well male breast cancer responds to preoperative
treatment with endocrine therapy and which endocrine therapy regimen is the most effective
treatment for male breast cancer.
The drugs used in this study are:
- Tamoxifen
- Anastrozole
- Degarelix
- Abemaciclib
Phase:
Phase 2
Details
Lead Sponsor:
Jose Pablo Leone
Collaborators:
Eli Lilly and Company Translational Breast Cancer Research Consortium (TBCRC)